ORAGENICS INC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
FL
Business Address
9015 TOWN CENTER PARKWAY, LAKEWOOD RANCH, FL, 34202
Mailing Address
9015 TOWN CENTER PARKWAY, LAKEWOOD RANCH, FL, 34202
Phone
8132867900
Fiscal Year End
1231
EIN
593410522
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 13, 2026 | View on SEC |
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| S-3/A Shelf registration amendment | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 11, 2026 | View on SEC |
| 4/A Insider transaction amendment | January 22, 2026 | View on SEC |
| 8-K Current report of material events | January 22, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 22, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Completed Phase 1 clinical trials for lead candidate ONP-002, demonstrating initial safety in humans.
- Filed patent applications for ONP-002 and its unique nasal delivery device, strengthening intellectual property.
Insider Trading
SELL
1 insiders
2 recent transactions
View Insider Trading Dashboard
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.